Harvard Bioscience Inc (NAS:HBIO)
$ 2.24 -0.08 (-3.45%) Market Cap: 101.19 Mil Enterprise Value: 143.19 Mil PE Ratio: 0 PB Ratio: 1.55 GF Score: 56/100

Q2 2024 Harvard Bioscience Inc Earnings Call Transcript

Aug 08, 2024 / 02:00PM GMT
Release Date Price: $3.12 (+11.83%)
Operator

Good day and thank you for standing by. Welcome to the Q2 2024 Harvard Bioscience, Inc. earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

(Operator Instructions) I would now like to hand the conference over to your speaker today, Kathryn Flynn, Corporate Controller.

Kathryn Flynn
Harvard Bioscience Inc - Corporate Controller

Thank you, Josh, and good morning, everyone. Thank you for joining the Harvard Bioscience second quarter 2024 earnings conference call. Leading the call today will be Jim Green, President and Chief Executive Officer; and Jennifer Cote, Chief Financial Officer. In conjunction with today's recorded call, we have provided a presentation that will be referenced during our remarks that is posted to the Investors section of our website at investor.harvardbioscience.com.

Please note that statements made in today's discussion that are not historical facts, including statements or expectations or future events or future financial performance are forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot